CELL SEARCH SYSTEM -CELL BANK- (RIKEN BRC) [RCB4474 : Ba/F3-CL1]

4829 Daley GQ1, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci U S A 1988 85(23):9312-6 PubMed ID: 3143116 DOI: 10.1073/pnas.85.23.9312

4828 Palacios R, Steinmetz M. Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 1985 41(3):727-34 PubMed ID: 3924409 DOI: 10.1016/s0092-8674(85)80053-2

4827 Palacios R, Henson G, Steinmetz M, McKearn JP. Interleukin-3 supports growth of mouse pre-B-cell clones in vitro. Nature 1984 309(5964):126-31 PubMed ID: 6201749 DOI: 10.1038/309126a0

Top

User's Publication

19766 Hamada A, Suda K, Nishino M, Obata K, Oiki H, Fukami T, Fukuda S, Fujino T, Ohara S, Koga T, Chiba M, Shimoji M, Ito M, Takemoto T, Soh J, Tsutani Y, Mitsudomi T. Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion J Thorac Oncol 2024 19(1):71-79 PubMed ID: 37666482 DOI: 10.1016/j.jtho.2023.08.029

19833 Arai A, Yoshimitsu M, Otsuka M, Ito Y, Miyazono T, Nakano N, Obama K, Nakashima H, Hanada S, Owatari S, Nakamura D, Tokunaga M, Kamada Y, Utsunomiya A, Haraguchi K, Hayashida M, Fujino S, Odawara J, Tabuchi T, Suzuki S, Hamada H, Kawamoto Y, Uchida Y, Hachiman M, Ishitsuka K. Identification of putative noncanonical driver mutations in patients with essential thrombocythemia Eur J Haematol 2023 110(6):639-647 PubMed ID: 36811253 DOI: 10.1111/ejh.13945

20412 Fujino T, Suda K, Sakai K, Murakami I, Shimizu S, Ohara S, Koga T, Hamada A, Soh J, Nishio K, Mitsudomi T. Intra-tumor and Inter-tumor Heterogeneity in MET Exon 14 Skipping Mutations and Co-mutations in Pulmonary Pleomorphic Carcinomas. Clin Lung Cancer 2022 PubMed ID: 34702670 DOI: 10.1016/j.cllc.2021.09.005

20407 Hamada A, Suda K, Koga T, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Soh J, Uchida T, Mitsudomi T. In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial. Lung Cancer 2021 162:79-85 PubMed ID: 34741886 DOI: 10.1016/j.lungcan.2021.10.014

20411 Ota Y, Yoda H, Inoue T, Watanabe T, Shinozaki Y, Takatori A, Nagase H. Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides. PLoS One 2021 16(9):e0257718 PubMed ID: 34591871 DOI: 10.1371/journal.pone.0257718

17935 Saito Y, Koya J, Araki M, Kogure Y, Shingaki S, Tabata M, McClure MB, Yoshifuji K, Matsumoto S, Isaka Y, Tanaka H, Kanai T, Miyano S, Shiraishi Y, Okuno Y, Kataoka K. Landscape and function of multiple mutations within individual oncogenes Nature 2020 582(7810):95-99 PubMed ID: 32494066 DOI: 10.1038/s41586-020-2175-2

11758 Yoshimitsu M, Hachiman M, Uchida Y, Arima N, Arai A, Kamada Y, Shide K, Ito M, Shimoda K, Ishitsuka K. Essential thrombocytosis attributed to JAK2-T875N germline mutation. Int. J. Hematol. 2019 10(5):584-590 PubMed ID: 31428969 DOI: 10.1007/s12185-019-02725-8

12392 Kashiwagi S, Fujioka Y, Kondo T, Satoh AO, Yoshida A, Fujioka M, Sasajima H, Amano M, Teshima T, Ohba Y. Localization of BCR-ABL to Stress Granules Contributes to Its Oncogenic Function Cell Struct Funct 2019 44(2):195-204 PubMed ID: 31735741 DOI: 10.1247/csf.19033